OPKO HEALTH INC (OPK:NASDAQ)
$1.42 0.12 (9.2308%)
Analysed OPKO HEALTH INC (OPK:NASDAQ) News Sources
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
28-04-2026
yahoo.com
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
28-04-2026
yahoo.com
OPKO Health Q1 Earnings Call Highlights
28-04-2026
marketbeat.com
OPKO Health Inc (OPK) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...
29-04-2026
yahoo.com
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
29-04-2026
yahoo.com
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
30-04-2026
yahoo.com
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
30-04-2026
yahoo.com
Spotlight On Promising Penny Stocks For May 2026
11-05-2026
yahoo.com
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
12-05-2026
yahoo.com
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
21-05-2026
yahoo.com
What is the current price of OPKO HEALTH INC (OPK:NASDAQ)?
The current price of OPKO HEALTH INC (OPK:NASDAQ) is $1.42.
OPKO HEALTH INC (OPK:NASDAQ) absolute price change since previous trading day?
The absolute price change of OPKO HEALTH INC (OPK:NASDAQ) since the previous trading day is $0.12.
OPKO HEALTH INC (OPK:NASDAQ) percentage price change since previous trading day?
The percentage price change of OPKO HEALTH INC (OPK:NASDAQ) since the previous trading day is 9.2308%.
What is the most recent average sentiment score for OPKO HEALTH INC (OPK:NASDAQ)?
The most recent average sentiment score for OPKO HEALTH INC (OPK:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for OPKO HEALTH INC (OPK:NASDAQ)?
The most recent sentiment for OPKO HEALTH INC (OPK:NASDAQ) is .
SEC-8K** Filing Available For OPKO HEALTH INC (OPK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.